1.

Which of the following has approved Itolizumab for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress syndrome?

A. WHO India
B. NITI Aayog
C. AIIMS Delhi
D. Drugs Controller General of India
E. Indian Institute of Health Management Research.
Answer» E. Indian Institute of Health Management Research.


Discussion

No Comment Found